Pharma-Bio Serv (OTCMKTS:PBSV) Trading Up 2.7% – Here’s What Happened
by Amy Steele · The Cerbat GemPharma-Bio Serv Inc. (OTCMKTS:PBSV – Get Free Report) traded up 2.7% on Monday . The stock traded as high as $0.58 and last traded at $0.58. Approximately 2,500 shares were traded during mid-day trading, an increase of 1,201% from the average daily volume of 192 shares. The stock had previously closed at $0.5650.
Pharma-Bio Serv Price Performance
The stock has a 50-day moving average price of $0.55 and a two-hundred day moving average price of $0.54.
Pharma-Bio Serv (OTCMKTS:PBSV – Get Free Report) last posted its earnings results on Monday, June 15th. The company reported $0.01 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.03 by ($0.02). Pharma-Bio Serv had a net margin of 0.68% and a return on equity of 0.56%. The business had revenue of $2.70 billion for the quarter, compared to analysts’ expectations of $2.70 million. On average, equities research analysts anticipate that Pharma-Bio Serv Inc. will post 0.07 earnings per share for the current year.
Pharma-Bio Serv Company Profile
Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc was founded in 1993 and is headquartered in Dorado, Puerto Rico.